- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Assistant Deans
- Associate Deans
- Education Unit
- Office of Academic Affairs
- Office of Finance and Administration
- Office of Planning and Communications
- Org chart
- Patient Care
Fri Mar 15, 2019
“Challenging the status quo leads to very good things,” said Glen L. Stimmel, PharmD ’72, who has spent a career doing just that. As a motto, it has served him, and his profession, quite well. Stimmel, the 2019 UCSF Pharmacy Alumni Association Distinguished Alumnus of the Year, has taken his own...
Tue Mar 12, 2019
The UCSF School of Pharmacy 2019 Mary Anne Koda-Kimble Seed Award for Innovation marked its fifth year of funding with a March 5 announcement of award recipients by the School’s dean, B. Joseph Guglielmo, PharmD. The multiple awards will fund research into neuroscience, cancer treatment, and...
Thu Mar 7, 2019
Scientists at UC San Francisco have discovered how a particular protein regulates dopamine production, creating new possibilities for research into Parkinson’s disease, which involves the loss of dopamine-producing neurons. The new research was partially funded by a Mary Anne Koda-Kimble Seed...
Thu Feb 28, 2019
UC San Francisco’s already successful research and education program in bioengineering is taking another evolutionary leap forward with the February 15, 2019 announcement of a new initiative being led by Tejal Desai, PhD, chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a...
Wed Feb 27, 2019
The UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the nation for the 39th year in a row. In total, the School took in $28.9 million in NIH grants in 2018. As a whole, UC San Francisco was the top public...
Wed Feb 27, 2019
A new fellowship offered at UC San Francisco promises to spur research into medicine quality through the study of the pharmacologically inactive ingredients in drugs, known as excipients. The U.S. Pharmacopeial Convention (USP) Quality Institute is partnering with UCSF to support the Fellowship in...
Fri Feb 22, 2019
This January, Susan Miller, PhD, a UCSF School of Pharmacy faculty member, and Scott Oakes, MD, a UCSF School of Medicine faculty member, jointly greeted an auditorium of UCSF medical and pharmacy students with a challenge instead of a syllabus: to explore. The course, called Inquiry Immersion,...
Tue Feb 12, 2019
A $500,000 gift from Linda Lloyd Hart, PharmD—matched by the University of California Office of the President with $500,000—recently established the endowed Jere E. Goyan Presidential Chair for the Advancement of Pharmacy. This is the UCSF School of Pharmacy’s first presidential chair. Hart, a...
Mon Feb 11, 2019
Ground-breaking drug discovery work by UCSF School of Pharmacy scientists, who search for drug candidates from stores of small molecules and through computer simulations, continued this week with the announcement of a new virtual library of more than 250 million drug-like compounds for researchers...
Mon Jan 28, 2019
When Jacqueline Kyosiimire-Lugemwa, PhD, arrived at UC San Francisco in January 2018, she was excited to finally have the tools and the team to analyze reams of data on people infected with HIV, which she had painstakingly collected for years in her home country of Uganda. But science doesn’t move...
Thu Jan 17, 2019
A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models using a modified version of the CRISPR gene editing system, called CRISPRa. Developed at UC San Francisco, CRISPRa (a for activation) doesn’t cut DNA like its CRISPR forerunner but...
Wed Jan 9, 2019
James Fraser, PhD, has been appointed to the Bowes Biomedical Investigator Program. Fraser studies the shapes and movements of macromolecules, a category of molecules that includes proteins and carbohydrates. Over the course of his career, he has developed several new tools for creating maps of...
Tue Jan 8, 2019
Computational biologist Michael Keiser, PhD, was recently awarded $2.5 million over five years to study neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, and speed the development of new drug therapies for these diseases using machine learning. Keiser is one of 17 investigators to...